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Key Clinical Message
Knowledge of anatomy is vital preimplant to screen the patient for the subcuta-
neous implantable defibrillator (S-ICD), particularly those who have previously
had thoracic surgery. X-ray screening in these patients is highly recommended.
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Case History
A 68-year-old woman was admitted following ventricular
fibrillation (VF) arrest. She was deaf and mute, with previ-
ous pulmonary tuberculosis (TB) as a child requiring right
lower lobectomy. Echocardiogram on admission showed
normal left ventricular (LV) size, mild concentric hyper-
trophy (IVSd 1.2 cm), no regional wall motion abnormali-
ties, mild mitral regurgitation, and ejection fraction (EF)
of 60%. ECG: no conduction or repolarization abnormali-
ties (QTc = 390 msec), ajmaline challenge was negative
for Brugada syndrome. Cranial computed tomography
(CT) showed no acute pathology and CT coronary angio-
gram showed unobstructed coronary arteries. Cardiac
magnetic resonance imaging (CMR) confirmed good LV
systolic function and no fibrosis. The decision was made
to implant a subcutaneous implantable defibrillator (S-
ICD). It was not appreciated by the team undertaking rou-
tine screening that the lobectomy had resulted in signifi-
cant midline shift (Fig. 1), and screening was performed
using the standardized approach. She passed in all three
vectors (electrode on left sternal border).
The patient was brought to the laboratory and a fluo-
roscopic screen of a dummy device was conducted
(Fig. 2). This showed a clear displacement of the heart to
the right hemithorax, and indicates that the shock vector
for the device would not have covered the heart in the
standard left lateral generator position. At this point, the
decision was made to implant the device on the right lat-
eral chest wall with the shock coil on the left sternal bor-
der to insure an optimal shock vector across the
ventricles (Fig. 3), and to maintain one fully screened
vector (alternate vector). During implant, a successful
defibrillation threshold test (DFT) at 65 J was achieved.
Postimplant optimization confirmed the patient had three
suitable sensing vectors. At 1-month follow-up, the
patient had no episodes recorded by the device.
Discussion
The S-ICD is becoming increasingly utilized in clinical
practice, with registry data supporting its efficacy for use
in a large variety of patients [1, 2]. Congenital heart dis-
ease which can provide challenging anatomy to enable
adequate shock and sensing vectors [3]. However, there
are no reports of using the S-ICD in a patient with a dis-
placed heart within the chest cavity following thoracic
surgery. Two previous cases describe S-ICD implantation
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in dextrocardia [4, 5]. This is an important consideration
and highlights the need to review chest radiographs
before screening such patients for implantation especially
those postcardiac and thoracic surgery or chest wall
abnormalities, for example, pectus excavatum.
With more widespread utilization of the S-ICD, its use
in difficult anatomies will increase to avoid the long-term
risks of transvenous lead implantation. The key issue is to
insure the optimal sensing and shock vectors tailored to
the patient’s anatomy. In this case, the can position was a
mirror of a standard implant, with the S-ICD on the right
lateral chest wall.
Conclusion
Knowledge of cardiac displacement before screening is
vital to insure the device is appropriate for the patient. X-
ray screening for lead localization is strongly recom-
mended in post-thoracic surgical patients as anatomies
can be significantly distorted leading to suboptimal device
placement.
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